Santa Barbara, CA and New York, NY -- The Glenn Foundation for Medical Research (GFMR) and the American Federation for Aging Research (AFAR) are pleased to announce the 2024 recipients of the Glenn Foundation Discovery Awards: Jeffrey Friedman, MD, PhD (Professor, The Rockefeller University and Investigator, Howard Hughes Medical Institute) and Myriam Heiman, PhD (Associate Professor of Neuroscience, Massachusetts Institute of Technology).
The Glenn Foundation Discovery Award supports research projects with strong potential to develop pioneering discoveries to understand the underlying biological mechanisms that govern normal human aging and its related physiological decline. Two, three-year awards of $525,000 are made annually ($175,000 per year for three years).
Dr. Friedman’s Discovery Award is titled “Cellular and Molecular Basis for Hypothalamus Aging.” By studying individual brain cells, Dr. Friedman aims to understand the changes that occur as we age. This knowledge could help develop new treatments for age-related diseases and improve overall health as we get older. Learn more about Dr. Friedman’s research here.
Dr. Heiman’s Discovery Award is titled “Charting the Cellular Rejuvenation Landscape in Aging Neurons.” Dr. Heiman aims to understand the mechanisms that underlie the exceptional longevity of nerve cells in our brain. If understood, these mechanisms could be targeted to restore nerve cell function in the context of aging and neurodegeneration and could also potentially be induced in other cell types of the body to increase the healthspan of the whole organism. Learn more about Dr. Heiman’s research here.
“The Glenn Foundation Discovery Award seeks to support investigators who have not previously been engaged in aging research, but whose research is relevant to understanding aging mechanisms and could lead to novel advances with significant potential to benefit human health and well-being,” states Mark R. Collins, President of the Glenn Foundation for Medical Research.
Notes Stephanie Lederman, EdM, Executive Director, AFAR: "The Discovery Awards create an opportunity for fresh perspectives to help better understand and therapeutically target the biological processes of aging. This not only this enriches the field of aging research at large but also paves the way toward interventions that will help us all live healthier, longer. AFAR is grateful for our decades-long partnership with the Glenn Foundation for Medical Research in various programs and for its visionary support of this highly impactful program.”
Learn more about the Glenn Foundation Discovery Award here.
###
About the Glenn Foundation for Medical Research - Founded by Paul F. Glenn in 1965, the mission of the Glenn Foundation for Medical Research is to extend the healthy years of life through research on mechanisms of biology that govern normal human aging and its related physiological decline, with the objective of translating research into interventions that will extend healthspan with lifespan. Learn more at glennfoundation.org.
About AFAR - The American Federation for Aging Research (AFAR) is a national non-profit organization that supports and advances pioneering biomedical research that is revolutionizing how we live healthier and longer. For more than four decades, AFAR has served as the field’s talent incubator, providing $212,500,000 to 4,460 investigators at premier research institutions to date—and growing. In 2024, AFAR expects to provide approximately $12,270,00 to 60 investigators. A trusted leader and strategist, AFAR also works with public and private funders to steer high quality grant programs and inter-disciplinary research networks. AFAR-funded researchers are finding that modifying basic cellular processes can delay—
or even prevent—many chronic diseases, often at the same time. They are discovering that it is never too late—or too early—to improve health. This groundbreaking science is paving the way for innovative new therapies that promise to improve and extend our quality of life—at any age. Learn more at www.afar.org.